Abstract
IntroductIon
Histologically, malignant lymphomas are characterized by a homogeneous neoplastic cell population and a tumor growth pattern either of cohesive cellular aggregates called the follicular or nodular pattern, or of diffuse infiltration. [1] Immunologically, lymphomas are expanded clones of lymphocytic precursors or functional cell types (B-or T-cell), which appear to develop from a block or switch on (de-repression) of lymphocytic transformation. Genetically, in most lymphoid neoplasms antigen receptor gene rearrangement precedes transformation of lymphoid cells; as a result, all daughter cells derived from the malignant progenitor share the same antigen receptor gene configuration and sequence and synthesize identical antigen receptor proteins (either Ig or T-cell receptor); whereas B-cell neoplasms are positive for surface immunoglobulin (sIg+) and/ or cytoplasmic immunoglobulin (cIg+), and express pan-B cell markers (CD19, CD20, CD22, and CD79α), T-cell neoplasms express T-cell markers such as CD2, CD3 (considered lineage specific), CD5, CD7, CD4, and CD8. [2] The cytodiagnosis of non-Hodgkin lymphoma (NHL) depends upon finding a relatively monotonous population of lymphoid cells [3, 4] and Hodgkin lymphoma (HL) is diagnosed in smears on finding Hodgkin and Reed-Sternberg (HRS) cells among reactive cell population which consists of lymphocytes, plasma cells, histiocytes, and eosinophils. [5, 6] Some of the limitations of FNA in cytodiagnosis of lymphoma include problem encountered in differentiating reactive hyperplasia from low-grade NHL, lower cytodiagnostic accuracy of NHL with a follicular (nodular) pattern, and nodular sclerosis type of classical HL, and overlapping morphological features between T-cell-rich B-cell lymphoma (TCRBCL), anaplastic large cell lymphoma (ALCL), and HL. [7] In order to overcome the diagnostic difficulties of lymphomas and their subtypes in FNA smears, immune-phenotyping is essential.
"WHO Classification of Hematopoietic and Lymphoid Neoplasms," [8] comprises nearly 100 subtypes of lymphoid neoplasms and their variants. The cytomorphology and ICC results of a few usual and unusual lymphoma subtypes, viz., CLL/small lymphocytic lymphoma including rare variants like T-cell prolymphocytic leukemia (T-PLL), follicular lymphoma (FL), mantle cell lymphoma (MCL), MALT lymphoma, diffuse large B-cell lymphoma (DLBCL) including T-cell/histiocyte-rich large B-cell lymphoma (THRBCL or TCRBCL), Burkitt lymphoma (BL), lymphoblastic lymphoma (LBL), ALCL, and HL, both nodular lymphocyte predominant (NLPHL) and classical type (CHL), are presented in this communication. Reference has been made mostly to the WHO monographs and a few journal articles for cytomorphological features and immunocyto/histochemical results. [7] [8] [9] [10] [11] [12] Small lymPhocytIc non-hodgkIn lymPhoma (chronIc lymPhocytIc leukemIa)
Most of the patients are elderly with generalized lymphadenopathy. The small lymphocytic lymphoma/ CLL cells are invariably of B-cell lineage with following immuno-phenotype: CD3-, CD5+, CD10-, CD19+, CD20+ (low), CD22+, CD23+, CD43+, CD79a+, and Ig+ (low). [8] FNA smear from the lymph nodes show features of a small lymphocytic lymphoma with a monotonous population of lymphoid cells consistent with CLL; [13] positive reaction for CD20 and CD5 is observed in neoplastic cells in FNA smears and/or peripheral blood smear whenever there is evidence of leukemic infiltration [ Figure 1 ]. T-cell CLL/T-prolymphocytic leukemia (T-PLL), which has an aggressive clinical course with a median survival of less than 1 year, account for less than 2% of all lympho-proliferative diseases and <5% of the total number of chronic lymphoproliferative disorders. [14, 15] In a report on a rare case of T-PLL by Das et al. [16] FNA smears from cervical lymph node showed a monomorphic population of small lymphoid cells with a frequent hand-mirror cell configuration, coarse chromatin, and small but distinct nucleoli; immunocytochemically the lymphoid cells were CD3+, CD4+, CD5+, CD7+, CD8-, CD20-, CD23-, and Tdt-[ Figure 2 ].
follIcular lymPhomaS
Middle-aged and older people are affected, and frequently present with generalized lymphadenopathy. Cytologically these cases could be centrocytic (CC), centroblastic (CB), or mixed centrocytic-centroblastic (CC-CB) type. The immunophenotype is Bcl2+, CD5-, CD10±, CD19+, CD23±, and CD43-in over 80% cases. [17] Whereas the centrocytic lymphomas (NHL-CC) show a monotonous population of CD20 positive atypical, small-to medium-sized lymphoid cells with variably irregular, indented, or cleaved nuclei having moderately clumped to more dispersed chromatin and inconspicuous nucleoli [ Figure 3a and b], the centrocytic-centroblastic lymphoma (NHL-CCCB) show a mixed cell population centrocytes and large centroblasts (large cleaved cells/large noncleaved cells), which are positive for CD20 and BCl2 [ Figure 3c -f]. The FNA smears in centroblastic lymphoma on the other hand contain mostly CD20 and BCl2 
the mantle cell lymPhoma
On cytologic preparations, MCLs comprise small-to medium-sized cells with delicate nuclear indentations, the chromatin generally being less clumped or coarse compared to small lymphocytic lymphoma. The immunophenotype is CD5+, CD10-, BCl2+, BCl6-, MUM1-, CD43+, CD23±, and cyclin D1+. [11] margInal Zone b-cell lymPhoma These cases are known as monocytoid B-cell lymphoma of the mucosal associated lymphoid tissue (MALT lymphoma). The smears show monomorphic population of small-to medium-sized lymphoid cells with plasmacytoid features and round or slightly irregular nuclei. Kaba et al. [18] described the FNA cytologic features of histologically and immunohistochemically proved MALT lymphomas as smears containing numerous plasma cells, lymphocytes with plasma cell differentiation and scattered centrocyte-like cells. The immunophenotype of MALT lymphoma is sIg+, CD5-, CD10-, CD19+, CD20+, CD22+, CD23-, CD43+, BCl2+, BCl6-, and cyclin D1-. [8, 11] large b-cell lymPhoma Large B-cell lymphomas are a heterogeneous group comprising centroblatic, immunoblastic, and anaplastic variants. [8] The large noncleaved cells (centroblasts) and immunoblasts are at least twice to thrice the size of small-cleaved cells; the cytoplasm is abundant, plasmacytoid, or clear to pale, and nuclei have round outlines, vesicular chromatin, and single to multiple prominent nucleoli, which are situated at the nuclear margin in centroblasts and central in immunoblasts. [9, 13] Cozzolino et al. [19] described the cytologic features of these cases comprising a predominant large and isolated cell population with irregular nuclear membrane and coarse, granular chromatin but with a pale appearance, and one or two eccentric nucleoli; the cytoplasm was often ill-preserved or occasionally absent imparting the appearance of naked large nuclei. When a large number of mature lymphocytes are present in the background, especially of T-cell origin, TCRBCL is a differential diagnostic possibility in cytologic preparations [ Figure 4e -h]. In histology most of these cases have a diffuse architectural pattern, hence, the name DLBCL. The immunohistochemical features include positive reaction for pan B-cell markers (CD19+, CD20+, CD22+, and CD79a+), CD10+ (30-60% cells), BCl6+ (60-90% cells), MUM1+ (35-65% cells), Ki67+ (>90% cells), and p53+ (20-60% cells). [8] Cozzolino et al. [19] divided the DLBCL cases into two groups based on gene expression profiling: germinal center B (GCB) and non-GCB and successfully studied immunocytochemical (ICC) profiles using CD10, BCl6, and MUM1 in 33 cases; ICC combinations were CD10-/BCl6-/MUM1+ (20 cases), and CD10+/BCl6+/MUM1-(8 cases) were the two most common among six different patterns, representing mostly non-GCB and GCB cases, respectively. Figure 5 ]. Besides pan B-cell markers, TCRBCL is BCl6+, BCl2+ (variable), EMA+ (variable), CD15-, CD30-, CD138-; the background mature cells are CD68+ histiocytes, and CD3+, and CD5+ T-cells. [8] While describing the limitations of FNA cytology in the diagnosis of TCRBCL, Das et al. [20] pointed out that TCRBCL may mostly be confused with HL (CD30+, CD15+, CD45-, B-, T-, EMA-) and ALCL (CD45+, CD30+, CD15-, T+, B-, EMA+, ALK1±); therefore, adequate immunocytochemical studies should be performed before diagnosing this rare neoplasm. According to Cheng and O'Connor, [21] various lymphoma types in which T-cell rich infiltrate is observed among large neoplastic B-cells are classical and nodular sclerosis type HL, TCRBCL, and angio-immunoblastic T-cell lymphoma. We also observed that in some DLBCL, there is variable amount of T-cell infiltration giving rise to confusion with TCRBCL.
burkItt lymPhoma
These cases have frequent extranodal disease. Unlike the African counterpart with frequent jaw tumor, abdominal mass is a common presentation in Indian cases. [22] The FNA smears from BL cases contain neoplastic lymphoid cells (10-12 μm in average size) with small noncleaved nuclei and scanty to moderate amount of deep basophilic cytoplasm having fine vacuoles due to neutral lipids and the neoplastic cells are interspersed with tingible body macrophages [ Figure 6a and b]; mitotic activity is invariably brisk. [22, 23] In our experience, BL is usually under diagnosed in histologic samples. [22, 24] The immunohistochemical profile of BL is as follows: mIgM (with light chain restriction), CD1a+, CD20+, CD22+, CD10+, CD38+, CD43+, CD77+, BCl2-(positive in 20% only), BCl6+, Tdt-, and Ki67+ (100% cells). [8] In FNA smears and imprint cytology, the neoplastic cells of BL are invariably of B-cell phenotype with kappa or lambda chain restriction. [25] Demonstration of Epstein-Barr virus (EBV) in BL is infrequent in nonendemic areas; in the case of BL mentioned above, Epstein-Barr virus nuclear antigen (EBNA) could be demonstrated along with CD20 and CD10 positivity and negative reaction for BCl2 in the cell block preparation of fine needle aspirates [ Figure 6c -f].
lymPhoblaStIc lymPhoma
FNA smears are characterized by intermediate-sized lymphoma cells (9.5-18.5 μm) with irregular nuclear contours, fine nuclear chromatin, inconspicuous nucleoli, and scant cytoplasm along with brisk mitotic activity. [26] These cases have frequent mediastinal mass and associated pleural effusion. [27, 28] Because of presence of high content of cells with nuclear convolutions (>50% in 61% cases), these cases were termed malignant lymphoma of convoluted lymphocytes in late-1970s and early-1980s, and their T-cell nature was confirmed by cytochemical staining (focal acid phosphatize and alpha-naphthyl acetate esterase positivity) and E-rosette tests. [27] In the following years, the T-cell nature of these neoplasms were established by detection T-cell immunophenotype (Tdt+, CD3+, CD5+, etc.) and T-cell receptor gene rearrangement studies; Jacobs et al. [26] observed T-cell phenotype in 14 cases and B-cell phenotype in one case only. Frequent hand-mirror cell configuration has been observed by us in the neoplastic cells, which were CD3+, CD20-, and Tdt+ [ Figure 7 ].
anaPlaStIc large cell lymPhoma ALCL, initially described as Ki-1 lymphoma in 1985, was characterized by pleomorphic appearing cells with horseshoe-shaped nucleus, which were immune-reactive for CD30 and EMA. [29] In 1994, the anaplastic lymphoma kinase (ALK) t (2;5) translocation took the place as the molecular morphologic counterpart to the hallmark cells. [30] The cytomorphologic features of ALCL include the following: 1) hallmark cells (because they are present in all variants) with eccentric, horseshoe-or kidney-shaped nuclei, which are typically large (but presence of smaller cells with similar morphology greatly aid in accurate diagnosis), 2) doughnut cells: cells with intranuclear inclusion, which represents invagination of cytoplasm into the nucleus. [30] [31] [32] ALCL is a T/null cell lymphoma with positive immunocytochemical staining for ALK-1 protein in 33% to 57% cases in cytologic specimen. [30, 32] ALCL can be distinguished from morphologically similar lesions by immunophenotype CD30+, CD45+, CD15-, EMA+, BNH9+, keratin-, lysozyme-; a recurrent cytogenetic translocation, t (2;5)(p23;q35). [33] Five morphologic patterns of ALCL can be recognized: the common pattern (60%), the lymphohistiocytic pattern (10%), the small cell pattern (5-18%), the Hodgkin-like pattern (3%), and the composite pattern (15%). [8] In addition, there are rare variants including one recently reported by Das et al. [34] an ALCL of the chest wall with peculiar cytoplasmic hyaline globules [ Figure 8 ] and marked variability in nuclear morphology including a teddy bear-shaped nucleus.
hodgkIn lymPhoma
Cytodiagnosis classical HL in FNA smears depends upon demonstration of Hodgkin and Reed-Sternberg (HRS) cells or their variants in an appropriate reactive cellular environment consisting of lymphocytes, plasma cell, histiocytes and eosinophils, and its subtyping is based on the relative proportion neoplastic HRS cells to reactive cellular components. [6] The current WHO classification of Hodgkin's lymphoma (HL) generally distinguishes the relatively rare variant of nodular lymphocytic predominant type (approximately 5% of all cases of HL) from a second group, which comprises classical HL and is separated into four subtypes: lymphocyte rich type, nodular sclerosis type, mixed cellular type, and lymphocyte depleted type. [35] The immunophenotype and genetic features are useful in the classification of HL and in distinguishing HL from two recently described, aggressive lymphomas that were in the past often diagnosed as HL, that is, anaplastic large-cell lymphoma, T-cell type, and T-cell/histiocyte-rich large B-cell lymphoma. [36] Das et al. [37] also found that ALCL and TCRBCL were the two NHL subtypes that created confusion with HL in FNA smears; in view of these investigators, [37] proper interpretation of cytologic features, together with immunocytochemical parameters can be of help in reducing the margin of error in cytodiagnosis of HL. Zhang et al. [38] described the FNA cytologic features of HL based on recent WHO classification. Whereas classical HL can be confirmed with the use of immunophenotype CD15+, CD30+, and CD45-, the nodular lymphocytic predominant HL has phenotype that includes LCA+, CD20+, CD79a+, CD15-, and CD30-[ Figure 9 ]. However, it will be necessary to extend this panel depending upon the differential diagnostic entities, especially when HL is associated with one or more other pathological lesions; these cases also highlight the limitations of cytodiagnosis when ICC panel is incomplete. [39, 40] One of the limitations of cytology in the field of lymphoreticular malignancy is its inability to diagnose the follicular pattern, which is a strict histopathological criterion. The small cell NHLs considered in the differential diagnosis of small lymphocytic lymphoma and FL, especially centrocytic type, are MCL and marginal zone/MALT lymphoma. [9] According to Young and Al-Salim, [9] the four subtypes of small cell NHL can be differentiated by a minimum panel of ICC reactions which is as follows: small lymphocytic NHL: CD10-, CD5+, and CD23+; MCL: CD10-, CD5+, and CD23-; FL: CD10+, CD5-, and CD23±; and MALT lymphoma: CD10-, CD5-, and CD23-. Based on cytomorphology, NHL of follicular center cell origin can be diagnosed when the lymphoma cell population consists of centrocytes or a mixture of centrocytes and centroblasts. A differential diagnosis of DLBCL comes into consideration when the population of lymphoma cell is almost exclusively centroblasts.
The greatest advantage of immunophenotyping of lymphoma in smears, especially cytospin preparations is that the cell morphology can be visually associated with immunophenotype; cell size, configuration, staining pattern, and intensity of staining; the background can be assessed simultaneously. [10] According to Sneige et al., [41] FNA used in association with ICC is a reliable tool for establishing the diagnosis and classification of majority of cases of lymphomas; 79% of the histologically confirmed lymphomas could be diagnosed and 7% were interpreted as suspicious of lymphoma by these investigators. Mihaescu et al. [42] found 20 cases of lymphomas and 26 suspicious lymphoma cases in a cytomorphological study of 95 effusions; these authors could detect eight additional cases of lymphomas by immunocytochemical studies and were also able to achieve lineage classification in 15 of 20 cases. According to Das et al., [43] cytomorphological features, along with contribution from ICC studies on fresh as well as archival smears of lymphomatous effusions, serve as useful tool in classifying NHL under the WHO system; however, the presence of appreciable number of cells with convoluted/lobulated nuclei may create difficulty in separating centroblastic lymphoma from lymphoblastic lymphoma, requiring the help of immunocytochemical study. According to Cozzolino et al., [19] the CD10-BCl6-MUM1 ICC algorithm is reliable in FNA specimen, and equally effective on conventional smear (CS) and cell block preparation (CB); it could subclassify DLBCL cases as germinal center B (GCB) type and non-GCB, which has prognostic implications, GCB group being associated with overall better survival. Higgins et al. [11] also observed that approximately 30-45% of DLBCL are germinal center phenotype (CD10+ or CD10-, BCl6+, and MUM1-) and 55-70% are non-germinal center phenotype (CD10-, BCl6±, and MUM1+) with better survival in germinal center type. A review by Rao [44] shows that besides having a role in subtyping of lymphomas based on morphology and immunohistochemistry (IHC), the latter parameter plays role in prognostication and targeted therapy of lymphoma cases, for example, (1) primary nodal DLBCL-germinal center type being associated with longer survival, (2) BCL2 positivity with MYC translocation in FL is associated with aggressive course, and (3) ALK positive ALCL has better prognosis than ALK negative cases (5-year survival 80% vs 48%).
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest. 
